Plasmacytoma - 153 Studies Found
| Completed |
: Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-02-20 :
|
| Completed |
: Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-02-05 :
|
| Completed |
: Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment : Multiple Myeloma and Plasma Cell Neoplasm : 2006-10-18 :
|
| Completed |
: Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2006-09-19 : Biological: anti-thymocyte globulin |
| Completed |
: Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2006-06-08 : Drug: fluphenazine hydrochloride |
| Completed |
: Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2006-06-07 :
|
| Completed |
: Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2006-04-24 :
|
| Completed |
: Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma :
: 2006-04-24 :
|
| Completed |
: Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2006-04-19 :
|
| Completed |
: Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2006-04-11 :
|